Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT2 | O15382 | 1/20 | 0.59 |
| ▸ | EIF4E | P06730 | 3/20 | 0.58 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.51 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.51 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.51 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.51 |
| ▸ | RORB | Q92753 | 1/20 | 0.51 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.49 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.49 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.47 |
| ▸ | FEN1 | P39748 | 1/20 | 0.47 |
| ▸ | AHR | P35869 | 2/20 | 0.46 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.44 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27474391 | 0.87 | BCAT2 (0.56) | BCAT2EIF4ECHEK1RORBPDK2 | |
| SCHEMBL3904946 | 0.85 | ALOX5AP (0.56) | BCAT2EIF4ECHEK1RORBCHRM1 | |
| SCHEMBL5273765 | 0.85 | CASP1 (0.59) | BCAT2EIF4ECHEK1CHRM1PDK2 | |
| SCHEMBL5381730 | 0.84 | PTGER1 (0.53) | EIF4EPTGER1PTGER3PTGER2RORB | |
| SCHEMBL3542609 | 0.84 | PTGER1 (0.56) | EIF4EPTGER1PTGER3PTGER2RORB | |
| SCHEMBL30029239 | 0.84 | EIF4E (0.46) | BCAT2EIF4EPTGER1PTGER3PTGER2 | |
| SCHEMBL1515709 | 0.83 | EIF4E (0.58) | EIF4EPTGER1PTGER3PTGER2CHEK1 | |
| SCHEMBL21357032 | 0.82 | PTGS2 (0.58) | BCAT2KMT2ANPC1MAPTRAB9A | |
| SCHEMBL5878337 | 0.81 | BCAT2 (0.87) | BCAT2CHEK1KMT2AALOX5APFEN1 | |
| SCHEMBL27922052 | 0.81 | MAPK14 (0.47) | EIF4ERORBMAPK14KMT2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1252140-B1 | PYRROLECARBOXAMIDES AND PYRROLETHIOAMIDES AS FUNGICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2009-05-13 | — | — | EP | claimed |
| EP-1813152-A1 | Fungicidal mixture based on 3,4-disubstituted biphenylanilides | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-01 | — | — | EP | claimed |
| EP-1042276-A1 | THIOUREA COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING OR PREVENTING INFLAMMATORY DISEASES AND ATHEROSCLEROSIS | WARNER-LAMBERT COMPANY LLC (US) | 2000-10-11 | — | — | EP | claimed |
| WO-1999032433-A1 | THIOUREA AND BENZAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING OR PREVENTING INFLAMMATORY DISEASES AND ATHEROSCLEROSIS | WARNER-LAMBERT COMPANY (US) | 1999-07-01 | — | — | WO | claimed |
| EP-0273444-A2 | Use of carboxamide compounds for the preparation of a medicament for treating hyperlipidemia | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 1988-07-06 | — | — | EP | claimed |
| EP-1856055-B1 | PYRAZOLE CARBOXYLIC ACID ANILIDES, METHOD FOR THE PRODUCTION THEREOF AND AGENTS CONTAINING THEM FOR CONTROLLING PATHOGENIC FUNGI | BASF SE (DE) | 2014-10-01 | — | — | EP | disclosed |
| WO-2014020351-A1 | RECEPTOR ANTAGONISTS | PROXIMAGEN LIMITED (GB) | 2014-02-06 | — | — | WO | disclosed |
| WO-2014020350-A1 | PAR2 RECEPTOR ANTAGONISTS | PROXIMAGEN LIMITED (GB) | 2014-02-06 | — | — | WO | disclosed |
| EP-2392662-A2 | Plant produtivity enhancement by combining chemical agents with transgenic modifications | BASF SE (DE) | 2011-12-07 | — | — | EP | disclosed |
| US-20100093715-A1 | Plant productivity enhancement by combining chemical agents with transgenic modifications | BASF SE (DE) | 2010-04-15 | — | — | US | disclosed |
| WO-2010015634-A1 | METHOD FOR SCREENING FOR A PLANT PROTECTANT | BASF SE (DE) | 2010-02-11 | — | — | WO | disclosed |
| EP-2076602-A2 | PLANT PRODUTIVITY ENHANCEMENT BY COMBINING CHEMICAL AGENTS WITH TRANSGENIC MODIFICATIONS | BASF SE (DE) | 2009-07-08 | — | — | EP | disclosed |
| WO-2008129060-A2 | PLANT PRODUTIVITY ENHANCEMENT BY COMBINING CHEMICAL AGENTS WITH TRANSGENIC MODIFICATIONS | BASF SE (DE) | 2008-10-30 | — | — | WO | disclosed |
| EP-1856055-A1 | PYRAZOLE CARBOXYLIC ACID ANILIDES, METHOD FOR THE PRODUCTION THEREOF AND AGENTS CONTAINING THEM FOR CONTROLLING PATHOGENIC FUNGI | BASF AKTIENGESELLSCHAFT (DE) | 2007-11-21 | — | — | EP | disclosed |
| EP-1813152-A1 | Fungicidal mixture based on 3,4-disubstituted biphenylanilides | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006087343-A1 | PYRAZOLE CARBOXYLIC ACID ANILIDES, METHOD FOR THE PRODUCTION THEREOF AND AGENTS CONTAINING THEM FOR CONTROLLING PATHOGENIC FUNGI | BASF AKTIENGESELLSCHAFT (DE) | 2006-08-24 | — | — | WO | disclosed |
| EP-0273444-A2 | Use of carboxamide compounds for the preparation of a medicament for treating hyperlipidemia | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 1988-07-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100093715-A1 | Plant productivity enhancement by combining chemical agents with transgenic modifications | CBR3, MYB, HACL2 | BCAT2 716/4885EIF4E 2769/4885PTGER1 2349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.